CAPRIUS INC
SC 13D, 2000-05-09
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: XCEED INC, SC 13G, 2000-05-09
Next: FRANKLIN TELECOMMUNICATIONS CORP, 10-Q, 2000-05-09




                                  UNITED STATES

                       SECURITIES AND EXCHANGE COMMISSION

                              Washington D.C. 20549

                                  SCHEDULE 13D

                    Under the Securities Exchange Act of 1934

                                  CAPRIUS, INC.
                                  -------------
                                (Name of Issuer)

                     Common Stock, par value $.01 per share
                     --------------------------------------
                         (Title of Class of Securities)

                                    14066K107
                                    ---------
                                 (CUSIP Number)

                                 Shrikant Mehta

                                354 Indusco Court

                              Troy, Michigan 48083

                                 (248) 585-9905

- ------------------------------------------------------------------------------
  (Name, Address and Telephone Number of Person Authorized to Receive Notices
                              and Communications)

                                 April 27, 2000
                                 --------------
            (Date of Event which Requires Filing of this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
Schedule because of Rule 13d-1(b)(3) or (4), check the following box <T058>.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934,  as amended (the "Act") or otherwise  subject to the  liabilities  of that
section of the Act but shall be subject to all  provisions  of the Act (however,
see the Notes).


<PAGE>

                                  SCHEDULE 13D

- --------------------- -------------- ----------------------------------
CUSIP No. 14066K107

- --------------------- -------------- ----------------------------------

- ------------ ----------------------------------------------------------
     1       NAME OF REPORTING PERSON
             S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

             SHRIKANT MEHTA


- ------------ ----------------------------------------------------------
     2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP   (a) [ ]
                                                                (b) [X]
- ------------ ----------------------------------------------------------
     3       SEC USE ONLY

- ------------ ----------------------------------------------------------
     4       SOURCE OF FUNDS

             PF
- ------------ -----------------------------------------------------------
     5       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
             PURSUANT TO ITEMS 2(d) or 2(e)                           [ ]

- ------------ -----------------------------------------------------------
     6       CITIZENSHIP OR PLACE OF ORGANIZATION

             UNITED STATES
- ------------------------- -------- -------------------------------------
                             7     SOLE VOTING POWER

       NUMBER OF

         SHARES                    4,100,000 shares (includes 2,900,000
                                   shares subject to warrants and options)
      BENEFICIALLY

        OWNED BY

          EACH

       REPORTING

      PERSON WITH
- ------------------------- -------- --------------------------------------
                             8     SHARED VOTING POWER

                                                     -0-

- ------------------------- -------- ---------------------------------------
                             9     SOLE DISPOSITIVE POWER

                                   4,100,000 shares (includes 2,900,000
                                   shares subject to warrants and options)
- ------------------------- -------- ---------------------------------------
                            10     SHARED DISPOSITIVE POWER

                                                     -0-
- ------------ -------------------------------------------------------------
    11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

             4,100,000 shares (includes 2,900,000 shares subject to
             warrants and options)
- ------------ -------------------------------------------------------------
    12       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
             CERTAIN SHARES                                            [ ]

- ------------ -------------------------------------------------------------
    13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

                               22.0%
- ------------ -------------------------------------------------------------
    14       TYPE OF REPORTING PERSON

                               IN
- ------------ -------------------------------------------------------------


                                   2
<PAGE>

ITEM 1.           SECURITY AND ISSUER.

                  This statement relates to the common stock, par value $.01 per
share (the  "Common  Stock"),  of CAPRIUS,  INC.,  a Delaware  corporation  (the
"Company"),  the principal  executive offices of which are located at One Parker
Plaza, Fort Lee, New Jersey 07024.

ITEM 2.           IDENTITY AND BACKGROUND.

                  (a)      Shrikant Mehta

                  (b)      354 Indusco Court, Troy, MI 48083

                  (c)      Mr. Mehta currently serves as the President and
Chief Executive Officer of Combine International, Inc.

                  (d)      During the past five years,  Mr. Mehta has not been
convicted in a criminal  proceeding  (excluding  traffic violations or similar
misdemeanors).

                  (e) During the past five years, Mr. Mehta has not been a party
to a  civil  proceeding  of a  judicial  or  administrative  body  of  competent
jurisdiction and as a result of such proceeding was or is subject to a judgment,
decree  or final  order  enjoining  future  violations  of,  or  prohibiting  or
mandating activities subject to, federal or state securities laws or finding any
violation with respect to such laws.

                  (f)      Mr. Mehta is a United States citizen.


ITEM 3.           SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

                  In April 2000,  Mr. Mehta  acquired  400,000 units  ("Units"),
which  consists of 1,200,000  shares of the Company's  Common  Stock,  1,600,000
Series A Warrants and 800,000 Series B Warrants, in a private placement offering
by the Company (the  "Placement")  for  $1,200,000.  The monies for the purchase
price came from Mr.  Mehta's  personal  funds.  Each Series A Warrant  gives the
holder the right to purchase one share of the Company's  Common Stock at a price
of $.50 and is  exercisable  for five  years.  Each  Series B Warrant  gives the
holder the right to purchase one share of Common Stock at a price of $.75 and is
exercisable for five years.

                  Additionally,  in consideration  for his  participation in the
Placement,  the Company separately agreed to grant Mr. Mehta options to purchase
500,000 shares of the Company's Common Stock, exercisable at $1.00 per share for
a period of three years.

ITEM 4.           PURPOSE OF TRANSACTION.

                  Mr.  Mehta  sought  an  interest  in the  Company  because  he
believes  that the Company has a  significant  amount of growth  potential.  The
Company's  Board of Directors and management  believe that the Company could use
his business experience and contacts to help facilitate such growth.

                  In consideration for his  participation in the Placement,  the
Company agreed to give Mr. Mehta, and other principal investors in the Placement
the right to  collectively  designate two members of the Board of Directors (the
"Designees"),  one of whom also shall be appointed to the Compensation Committee
of the Board of Directors;  provided,  however,  the Designees  were  reasonably
acceptable to the current Board of Directors. The Designees, one of which is Mr.
Mehta,  shall be added to the Board of  Directors  at its next  meeting  to fill
vacancies  created by the recent  resignations of two directors  pursuant to the
terms of the  Placement.  At each  meeting of  stockholders  for the election of
directors  held at any time prior to March 27, 2003,  the Company  shall include
the two  Designees  on the  management  slate of  directors,  subject to certain
conditions regarding the interest in the Company Mr. Mehta then holds.


                                  3
<PAGE>

                  Mr. Mehta will evaluate  business  opportunities and engage in
transactions that he and the Board of Directors deem to be in the best interests
of the Company,  including disposing of certain assets and other acquisitions or
dispositions. Other than as set forth herein, Mr. Mehta has no present intention
to engage or to cause the Company to engage in any other  transactions  referred
to in Paragraphs (a) through (j) of this Item, except that he may, either singly
or with others,  acquire additional  securities of the Company or dispose of all
or part of the Shares,  in open  market or  privately  negotiated  transactions,
depending upon market conditions and other investment considerations existing at
the time of any such transaction.

ITEM 5.           INTEREST IN SECURITIES OF THE ISSUER.

                  (a) Mr. Mehta  beneficially  owns  4,100,000  shares of Common
Stock (the "Shares"),  consisting of (i) 1,200,000 shares of Common Stock,  (ii)
1,600,000 shares upon the exercise of Series A Warrants at $.50 per share, (iii)
800,000 shares upon the exercise of Series B Warrants at $.50 per share and (iv)
500,000 shares  subject to options with an exercise price of $1.00.  Both series
of warrants and the options expire in March 2005.  Mr. Mehta's Shares  represent
approximately  22.0% of the issued and outstanding shares of Common Stock of the
Company,  based upon 13,525,517 shares issued and outstanding as of December 31,
1999 (as  reported  in the  Company's  Form 10-Q for the  fiscal  quarter  ended
December 31, 1999),  plus 1,950,000 shares issued upon the Placement and 225,000
shares  issued to two former  executive  officers  pursuant to their  respective
Consulting Agreements.

                  (b)      Mr. Mehta possesses the sole power to vote and the
sole power to dispose or to direct the  disposition  with respect to the Shares.

                  (c)-(e)  Not applicable.


ITEM 6.           CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
                  RESPECT TO SECURITIES OF THE ISSUER.

                  Mr.  Mehta and other  principal  investors  in the  Placement,
separately agreed to vote all of their Shares, which they beneficially own as of
the applicable  record date,  for Jonathan Joels and George Aaron,  both current
directors of the Company,  at each meeting of  stockholders or in any consent in
lieu of a meeting of stockholders with respect to the election of directors held
at any time prior to March 27, 2003. Mr. Joels and Mr. Aaron reciprocally agreed
to vote all of their Shares,  which they  beneficially  own as of the applicable
record  date,  for Mr.  Mehta  and  the  other  Designee,  at  each  meeting  of
stockholders or in any consent in lieu of a meeting of stockholders with respect
to the election of directors held at any time prior to March 27, 2003.

                  The  Company  separately  agreed  to give Mr.  Mehta and other
principal  investors in the  Placement the right to  collectively  designate two
members of the Board of Directors as described above in Item 4.

                  In consideration of their participation in the Placement,  the
Company separately agreed to give Mr. Mehta and other principal investors in the
Placement  preemptive  rights for a period of three years with  respect to their
interest in the Company,  such that, to the extent of their current  interest in
the Company,  Mr. Mehta and the other principal investors each have the right to
participate in any sale, for cash, of Common Stock or shares of preferred  stock
or other  securities  of the  Company  (the  "Derivative  Securities")  that are
exercisable for,  convertible into or exchangeable for shares of Common Stock in
a private  placement  transaction  pursuant to the exemption  from  registration
under Regulation D of the Securities Act of 1933, subject to certain exceptions.

                  The  Company  also  agreed  to  provide  Mr.  Mehta  and other
principal  investors in the Placement with most favorable investors rights, such
that if any  greater  rights are  received  by the holders of the next rounds of
equity  financing  of the  Company  occurring  within one year after the date of
purchase ("Subsequent Investments"),  subject to certain exceptions, the Company
shall prepare,  execute,  and deliver a revised  subscription  agreement,  stock
certificates,  warrants,  and any other documents necessary to put Mr. Mehta and
the  other  principal  investors  in the same  position  as the  holders  of any
Subsequent Investments. Furthermore, in the event that any Subsequent Investment


                                  4
<PAGE>


is at a price  per  share of less than the  equivalent  of  $0.722  per share of
Common Stock  (i.e.,  less than $0.722 per share of equity  security  (including
exercise  price, if any)  exercisable  for or convertible  into one share of the
Company's  Common  Stock),  then the Company shall issue to Mr.  Mehta,  without
additional  consideration,  the  number of shares of Common  Stock that he would
have  received  if  he  had  made  his  $1,200,000  investment  as a  Subsequent
Investment.

ITEM 7.           MATERIAL TO BE FILED AS EXHIBITS.

                  None.  The Stock  Purchase  Agreement,  form of Series A and B
Warrants  and side  agreements  with  respect  to the  Placement  were  filed as
exhibits  to a Form  8-K  filed  by the  Company  on  April  28,  2000,  and are
incorporated herein.



                                  5

<PAGE>



                                    SIGNATURE

                  After  reasonable  inquiry and to the best of my knowledge and
belief,  I certify  that the  information  set forth in the  statement  is true,
complete and correct.

                                                   /s/ Shrikant Mehta
                                                  -----------------------------
                                                         SHRIKANT  MEHTA

Dated:  May 9, 2000




                                  6



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission